Lonza Group AG Lonza Group AG

Lonza Group AG

LONN

Classifica tra le azioni #449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Prezzo delle azioni
$763.31
Capitalizzazione di mercato
$53.31B
Variazione (1 giorno)
0.87%
Variazione (1 anno)
8.49%
Paese
CH
Scambia Lonza Group AG (LONN)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Lonza Group AG (LONN)
L’azione Lonza Group AG (simbolo: LONN) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Oct 22, 2026.
Una quota di LONN acquistata prima di Oct 22, 2026 equivale oggi a 0 quote di LONN.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
US
1 x3
AU
0 -
NL
1 x100
BE